BioSpace News Archive

Hangzhou Sciwind Biosciences Co., Ltd. announced the appointment of Dr. Weidong Zhong, former co-founder and executive of Terns Pharmaceuticals, as Chief Strategy Officer and President of its US subsidiary, Sciwind Biosciences USA.

Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, announced that the first patient has been dosed in a Phase 1 study of IBI323, an anti-LAG-3/PD-L1 bispecific antibody.

Nucleix, a liquid biopsy company revolutionizing cancer treatment by detecting the disease earlier, announced data from two abstracts featuring its Bladder EpiCheck® test at the 36th Annual European Association of Urology Virtual Congress.

Kintor Pharmaceutical Limited, a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, announced that the U.S. Food and Drug Administration has greenlighted pyrilutamide’s phase II clinical trial for androgenetic alopecia to be conducted in the US.